ETCTN Randomized Phase II Trial of Topotecan plus M6620 (VX-970, Berzosertib) vs. Topotecan alone in Patients with Relapsed Small-Cell Lung Cancer Adult CIRB - Early Phase Emphasis Active Available to Open